A newly developed antibiotic called EVG7 could offer a powerful new way to stop Clostridioides difficile, a dangerous gut bacterium that often returns after treatment. In mouse studies, researchers ...
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of ...
Patients in American hospitals and long-term care facilities face a growing threat from Candida auris, a drug-resistant ...
A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...
The breadth of the proposal suggests that many organizations will need to reassess existing policies, contractual ...
IN THE SPACE of less than a decade, medicine acquired a means of doing what millennia of diets and exhortation could not. A ...
The Jharkhand High Court has acquitted a man convicted under the NDPS Act for allegedly carrying 11 kg of ganja, after a ...
Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...
Antibiotics can temporarily affect the gut microbiome by disrupting beneficial bacteria in your body. For most people, the microbiome begins to recover after treatment ends, although some changes may ...
Scientists have identified a cluster of genes in a common soil bacterium that produce a range of antibiotics that can act against multidrug-resistant bacteria. Researchers say that the discovery could ...
All of the enzymes required for a microorganism to synthesize a natural product are encoded by a self-contained, continuous genetic unit known as a biosynthetic gene cluster (BGC) 9. The diversity of ...